For most investors, how much a stock's price changes over time is important. Not only can it impact your investment portfolio, but it can also help you compare investment results across sectors and ...

Boston Scientific’s BSX robust MedSurg segment, driven by endoscopy, neuromodulation and urology businesses, is poised for further growth in the upcoming quarters. The long-term prospects of the ...

Patients whose atrial fibrillation lasts longer than seven days and who do not respond well to drug therapy are now eligible ...

Boston Scientific (NYSE: BSX) announced that the FDA approved an expansion to the label of its Farapulse pulsed field ablation (PFA) system.

Boston Scientific has struck a deal to buy medical-device maker Silk Road Medical for about $1.26 billion, adding a technology for stroke prevention to its vascular portfolio.

Trefis estimates Boston Scientific’s Q1 2023 revenues to be around $3.2 billion, aligning with the consensus estimate and reflecting a mid-single-digit y-o-y growth.

Boston Scientific Q4 revenue rose 22.4% Y/Y to $4.56B, exceeding the $4.424B consensus. Adjusted EPS of $0.70 beat expectations of $0.66. Cardiovascular sales grew 28.8% to $2.94B, with cardiology ...

Boston Scientific BSX posted another quarter of robust results. As the firm is on track to meet our full-year expectations, we’re leaving our $55 fair value estimate unchanged.

Medical device maker Boston Scientific said on Monday it had agreed to buy Axonics Inc for $3.7 billion, gaining access to devices used to improve bladder function.

Medical-products company Boston Scientific reported third-quarter results before market open. Last Updated: Oct. 23, 2024 at 7:39 a.m. ET First Published: Oct. 23, 2024 at 6:55 a.m. ET.

Summary. Boston Scientific's stock surged 58% over the past year, but high valuation and limited upside suggest caution and a 'hold' rating. Despite strong revenue growth and innovative products ...

Marlborough, Massachusetts-based Boston Scientific made $909 million from neuromodulation products including the Precision line last year, and Redwood City, California-based Nevro made ore than ...